Congressional committee looking into increases in drug prices

Howard Schiller, interim CEO of Valeant Pharmaceuticals International Inc., is planning to testify at a congressional hearing next week that will explore drug-price increases, according to a company spokeswoman.

Also in connection with the hearing, the House Committee on Oversight and Government Reform has subpoenaed Martin Shkreli and ordered him to testify, according to two people familiar with the matter.